Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Glycogenic hepatopathy as an unusual etiology of deranged liver function in a patient with type 1 diabetes: A case report.

Lui DT, Woo YC, Chow WS, Lee CH, Lee AC, Leung EK, Tan KC, Lam KS, Lam JK.

Medicine (Baltimore). 2019 Apr;98(17):e15296. doi: 10.1097/MD.0000000000015296.

2.

Erratum. Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans. Diabetes 2008;57:1246-1253.

Zhang X, Yeung DCY, Karpisek M, Stejskal D, Zhou ZG, Liu F, Wong RLC, Chow WS, Tso AWK, Lam KSL, Xu A.

Diabetes. 2019 Jan;68(1):235. doi: 10.2337/db19-er01c. Epub 2018 Nov 19. No abstract available.

3.

Genetic Regulation of Pigment Epithelium-Derived Factor (PEDF): An Exome-Chip Association Analysis in Chinese Subjects With Type 2 Diabetes.

Cheung CYY, Lee CH, Tang CS, Xu A, Au KW, Fong CHY, Ng KKK, Kwok KHM, Chow WS, Woo YC, Yuen MMA, Hai J, Tan KCB, Lam TH, Tse HF, Sham PC, Lam KSL.

Diabetes. 2019 Jan;68(1):198-206. doi: 10.2337/db18-0500. Epub 2018 Oct 10.

4.

Prospective associations of circulating adipocyte fatty acid-binding protein levels with risks of renal outcomes and mortality in type 2 diabetes.

Lee CH, Cheung CYY, Woo YC, Lui DTW, Yuen MMA, Fong CHY, Chow WS, Xu A, Lam KSL.

Diabetologia. 2019 Jan;62(1):169-177. doi: 10.1007/s00125-018-4742-8. Epub 2018 Sep 28.

PMID:
30267180
5.

Circulating Adipocyte Fatty Acid-Binding Protein Concentrations Predict Multiple Mortality Outcomes among Men and Women with Diabetes.

Lee CH, Cheung CYY, Woo YC, Lui DTW, Yuen MMA, Fong CHY, Chow WS, Xu A, Lam KSL.

Clin Chem. 2018 Oct;64(10):1496-1504. doi: 10.1373/clinchem.2018.289157. Epub 2018 Jul 18.

6.

Dapagliflozin and Empagliflozin Ameliorate Hepatic Dysfunction Among Chinese Subjects with Diabetes in Part Through Glycemic Improvement: A Single-Center, Retrospective, Observational Study.

Lee PCH, Gu Y, Yeung MY, Fong CHY, Woo YC, Chow WS, Tan K, Lam KSL.

Diabetes Ther. 2018 Feb;9(1):285-295. doi: 10.1007/s13300-017-0355-3. Epub 2018 Jan 10.

7.

Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus.

Lee CH, Woo YC, Chow WS, Cheung CYY, Fong CHY, Yuen MMA, Xu A, Tse HF, Lam KSL.

J Am Heart Assoc. 2017 Jun 6;6(6). pii: e005344. doi: 10.1161/JAHA.116.005344.

8.

Declining Trends of Cardiovascular-Renal Complications and Mortality in Type 2 Diabetes: The Hong Kong Diabetes Database.

Luk AOY, Hui EMT, Sin MC, Yeung CY, Chow WS, Ho AYY, Hung HF, Kan E, Ng CM, So WY, Yeung CK, Chan KS, Chan KW, Chan PF, Siu SC, Tiu SC, Yeung VTF, Chan JCN, Chan FWK, Cheung C, Cheung NT, Ho ST, Lam KSL, Yu LWL, Chao D, Lau IT.

Diabetes Care. 2017 Jul;40(7):928-935. doi: 10.2337/dc16-2354. Epub 2017 May 10.

PMID:
28490423
9.

An Exome-Chip Association Analysis in Chinese Subjects Reveals a Functional Missense Variant of GCKR That Regulates FGF21 Levels.

Cheung CYY, Tang CS, Xu A, Lee CH, Au KW, Xu L, Fong CHY, Kwok KHM, Chow WS, Woo YC, Yuen MMA, Cherny SS, Hai J, Cheung BMY, Tan KCB, Lam TH, Tse HF, Sham PC, Lam KSL.

Diabetes. 2017 Jun;66(6):1723-1728. doi: 10.2337/db16-1384. Epub 2017 Apr 6.

10.

Impact of Genetic Loci Identified in Genome-Wide Association Studies on Diabetic Retinopathy in Chinese Patients With Type 2 Diabetes.

Cheung CY, Hui EY, Lee CH, Kwok KH, Gangwani RA, Li KK, Chan JC, Woo YC, Chow WS, Yuen MM, Wong RL, Fong CH, Xu A, Wong DS, Sham PC, Lam KS.

Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5518-5524. doi: 10.1167/iovs.16-20094.

PMID:
27768789
11.

Exome-chip association analysis reveals an Asian-specific missense variant in PAX4 associated with type 2 diabetes in Chinese individuals.

Cheung CY, Tang CS, Xu A, Lee CH, Au KW, Xu L, Fong CH, Kwok KH, Chow WS, Woo YC, Yuen MM, Hai JS, Jin YL, Cheung BM, Tan KC, Cherny SS, Zhu F, Zhu T, Thomas GN, Cheng KK, Jiang CQ, Lam TH, Tse HF, Sham PC, Lam KS.

Diabetologia. 2017 Jan;60(1):107-115. Epub 2016 Oct 15.

PMID:
27744525
12.

Hypoadiponectinemia as an independent predictor for the progression of carotid atherosclerosis: a 5-year prospective study.

Hui E, Xu A, Chow WS, Lee PC, Fong CH, Cheung SC, Tse HF, Chau MT, Cheung BM, Lam KS.

Metab Syndr Relat Disord. 2014 Dec;12(10):517-22. doi: 10.1089/met.2014.0024. Epub 2014 Sep 11.

13.

Elevated circulating pigment epithelium-derived factor predicts the progression of diabetic nephropathy in patients with type 2 diabetes.

Hui E, Yeung CY, Lee PC, Woo YC, Fong CH, Chow WS, Xu A, Lam KS.

J Clin Endocrinol Metab. 2014 Nov;99(11):E2169-77. doi: 10.1210/jc.2014-2235. Epub 2014 Aug 28.

14.

Carbamylation of LDL and its relationship with myeloperoxidase in type 2 diabetes mellitus.

Shiu SW, Xiao SM, Wong Y, Chow WS, Lam KS, Tan KC.

Clin Sci (Lond). 2014 Jan;126(2):175-81. doi: 10.1042/CS20130369.

PMID:
23905837
15.

Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.

Chow WS, Xu A, Woo YC, Tso AW, Cheung SC, Fong CH, Tse HF, Chau MT, Cheung BM, Lam KS.

Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2454-9. doi: 10.1161/ATVBAHA.113.301599. Epub 2013 Jul 25.

PMID:
23887638
16.

Elevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study.

Chow WS, Tso AW, Xu A, Yuen MM, Fong CH, Lam TH, Lo SV, Tse HF, Woo YC, Yeung CY, Cheung BM, Lam KS.

J Am Heart Assoc. 2013 Jan 15;2(1):e004176. doi: 10.1161/JAHA.112.004176.

17.

Delayed diagnosis of 22q11.2 deletion syndrome in an adult Chinese lady.

Shea YF, Lee CH, Gill H, Chow WS, Lam YM, Luk HM, Lam ST, Chu LW.

Chin Med J (Engl). 2012 Aug;125(16):2945-7.

PMID:
22932096
18.

A man with a blistering eruption and tuberculosis.

Lee CH, Yuen MM, Chow WS, Tso AW, Yeung CK, Chan JC, Chau CH, Lam KS.

BMJ. 2012 Jan 6;344:d8351. doi: 10.1136/bmj.d8351. No abstract available.

PMID:
22228698
19.

A woman with raised alkaline phosphatase and forearm deformity.

Lam JK, Lam KS, Kung AW, Tan KC, Chow WS, Tso AW.

BMJ. 2011 Jun 15;342:d3435. doi: 10.1136/bmj.d3435. No abstract available.

PMID:
21677018
20.

An endoscopic modification of the simultaneous 'above and below' approach to large pituitary adenomas.

Leung GK, Yuen MM, Chow WS, Tse PY, Lui WM.

Pituitary. 2012 Jun;15(2):237-41. doi: 10.1007/s11102-011-0319-y. Erratum in: Pituitary. 2012 Jun;15(2):242. Yuen, Michelle Mae Ann [corrected to Yuen, Michele Mae Ann].

21.

An "unforeseen" complication of urinary tract infection in a patient with diabetes.

Yuen MM, Tam TC, Lau WW, Chan JF, Chow WS, Lam KS.

BMJ. 2010 Aug 18;341:c3073. doi: 10.1136/bmj.c3073. No abstract available.

PMID:
20719842
22.

A woman with hypophosphataemia and raised alkaline phosphatase.

Lam JK, Lam KS, Tan KC, Chow WS, Tso AW, Kung AW.

BMJ. 2010 Jan 20;340:b5564. doi: 10.1136/bmj.b5564. No abstract available.

PMID:
20089574
23.

Adipose tissue and the metabolic syndrome: focusing on adiponectin and several novel adipokines.

Tso AW, Xu A, Chow WS, Lam KS.

Biomark Med. 2008 Jun;2(3):239-52. doi: 10.2217/17520363.2.3.239.

PMID:
20477413
24.

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans.

Zhang X, Yeung DC, Karpisek M, Stejskal D, Zhou ZG, Liu F, Wong RL, Chow WS, Tso AW, Lam KS, Xu A.

Diabetes. 2008 May;57(5):1246-53. doi: 10.2337/db07-1476. Epub 2008 Feb 5. Erratum in: Diabetes. 2019 Jan;68(1):235.

25.

Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study.

Chow WS, Cheung BM, Tso AW, Xu A, Wat NM, Fong CH, Ong LH, Tam S, Tan KC, Janus ED, Lam TH, Lam KS.

Hypertension. 2007 Jun;49(6):1455-61. Epub 2007 Apr 23.

PMID:
17452504
26.

Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans.

Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang J, Tso AW, Chow WS, Wat NM, Xu JY, Hoo RL, Xu A.

Clin Chem. 2007 Jan;53(1):34-41. Epub 2006 Oct 13.

27.

Advanced glycation endproducts in nondiabetic patients with obstructive sleep apnea.

Tan KC, Chow WS, Lam JC, Lam B, Bucala R, Betteridge J, Ip MS.

Sleep. 2006 Mar;29(3):329-33.

PMID:
16553018
28.

HDL dysfunction in obstructive sleep apnea.

Tan KC, Chow WS, Lam JC, Lam B, Wong WK, Tam S, Ip MS.

Atherosclerosis. 2006 Feb;184(2):377-82. Epub 2005 Jun 21.

PMID:
15975582
29.

Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice.

Xu A, Lam MC, Chan KW, Wang Y, Zhang J, Hoo RL, Xu JY, Chen B, Chow WS, Tso AW, Lam KS.

Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6086-91. Epub 2005 Apr 18.

30.

Clinical hyperthyroidism in Chinese patients with stable HIV disease.

Wong KH, Chow WS, Lee SS.

Clin Infect Dis. 2004 Oct 15;39(8):1257-9. No abstract available.

PMID:
15486861
31.

Association between acute-phase reactants and advanced glycation end products in type 2 diabetes.

Tan KC, Chow WS, Tam S, Bucala R, Betteridge J.

Diabetes Care. 2004 Jan;27(1):223-8.

PMID:
14693993
32.

Metastatic melanoma of the pituitary gland. Case report.

Leung GK, Chow WS, Tan KC, Fan YW, Lam KS.

J Neurosurg. 2003 Nov;99(5):913-5.

PMID:
14609173
33.

Effect of losartan on plasma C-reactive protein in type 2 diabetic patients with microabluminuria.

Tan K, Chow WS, Wong Y, Shiu S, Tam S.

Diabetes Care. 2002 Jul;25(7):1254-5. No abstract available.

PMID:
12087039
34.

Advanced glycation end products and endothelial dysfunction in type 2 diabetes.

Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS.

Diabetes Care. 2002 Jun;25(6):1055-9.

PMID:
12032114
35.

Supplemental Content

Loading ...
Support Center